Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| P3 Health Partners Inc. | 768,868 | reported | 02 Aug 2023 | tx 3+1,368,868 |
| Immudyne, Inc. | 337,500 | reported | 11 May 2026 | tx 1+337,500 |
| Diplomat Pharmacy, Inc. | 26,052 | reported | 29 Mar 2019 | tx 7+254,602−2,166 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 11 May 2026 | GRANT_AWARD | Immudyne, Inc. | 337,500 | 0.00 USD | |
| 02 Aug 2023 | GRANT_AWARD | P3 Health Partners Inc. | 750,000 | 0.00 USD | |
| 15 May 2023 | PURCHASE | P3 Health Partners Inc. | 18,868 | 2.65 USD | first after silence |
| 12 Dec 2022 | GRANT_AWARD | P3 Health Partners Inc. | 600,000 | 0.00 USD | deriv |
| 29 Mar 2019 | SALE | Diplomat Pharmacy, Inc. | 901 | 5.82 USD | |
| 18 Mar 2019 | GRANT_AWARD | Diplomat Pharmacy, Inc. | 15,118 | 0.00 USD | |
| 19 Mar 2019 | SALE | Diplomat Pharmacy, Inc. | 1,265 | 5.84 USD | |
| 27 Mar 2018 | GRANT_AWARD | Diplomat Pharmacy, Inc. | 11,100 | 0.00 USD | |
| 27 Mar 2018 | GRANT_AWARD | Diplomat Pharmacy, Inc. | 26,384 | 0.00 USD | deriv |
| 20 Nov 2017 | PURCHASE | Diplomat Pharmacy, Inc. | 2,000 | 15.00 USD | |
| 01 May 2017 | GRANT_AWARD | Diplomat Pharmacy, Inc. | 200,000 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 15 May 2023.